SG11201610432UA - Formulated receptor polypeptides and related methods - Google Patents

Formulated receptor polypeptides and related methods

Info

Publication number
SG11201610432UA
SG11201610432UA SG11201610432UA SG11201610432UA SG11201610432UA SG 11201610432U A SG11201610432U A SG 11201610432UA SG 11201610432U A SG11201610432U A SG 11201610432UA SG 11201610432U A SG11201610432U A SG 11201610432UA SG 11201610432U A SG11201610432U A SG 11201610432UA
Authority
SG
Singapore
Prior art keywords
formulated
related methods
receptor polypeptides
polypeptides
receptor
Prior art date
Application number
SG11201610432UA
Inventor
Christopher Michael Haqq
Ramil Latypov
Original Assignee
Santa Maria Biotherapeutics Inc
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201462012104P priority Critical
Priority to US201462047995P priority
Priority to US201462058789P priority
Priority to US201562142812P priority
Application filed by Santa Maria Biotherapeutics Inc, Amgen Inc filed Critical Santa Maria Biotherapeutics Inc
Priority to PCT/US2015/035818 priority patent/WO2015192127A2/en
Publication of SG11201610432UA publication Critical patent/SG11201610432UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
SG11201610432UA 2014-06-13 2015-06-15 Formulated receptor polypeptides and related methods SG11201610432UA (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US201462012104P true 2014-06-13 2014-06-13
US201462047995P true 2014-09-09 2014-09-09
US201462058789P true 2014-10-02 2014-10-02
US201562142812P true 2015-04-03 2015-04-03
PCT/US2015/035818 WO2015192127A2 (en) 2014-06-13 2015-06-15 Formulated receptor polypeptides and related methods

Publications (1)

Publication Number Publication Date
SG11201610432UA true SG11201610432UA (en) 2017-01-27

Family

ID=54834575

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201610432UA SG11201610432UA (en) 2014-06-13 2015-06-15 Formulated receptor polypeptides and related methods

Country Status (17)

Country Link
EP (1) EP3155008A4 (en)
JP (1) JP2017519009A (en)
KR (1) KR20170035891A (en)
CN (1) CN107074931A (en)
AP (1) AP201609647A0 (en)
AU (1) AU2015274293A1 (en)
BR (1) BR112016029211A2 (en)
CA (1) CA2952231A1 (en)
CL (1) CL2016003191A1 (en)
EA (1) EA201692568A1 (en)
MX (1) MX2016016281A (en)
PE (1) PE20170471A1 (en)
PH (1) PH12016502479A1 (en)
SG (1) SG11201610432UA (en)
TN (1) TN2016000551A1 (en)
TW (1) TW201625675A (en)
WO (1) WO2015192127A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
CN103432568A (en) 2005-11-23 2013-12-11 阿塞勒隆制药公司 Activin-ActRIIa antagonists and uses for promoting bone growth
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
US9526759B2 (en) 2007-02-01 2016-12-27 Acceleron Pharma Inc. Activin-actriia antagonists and uses for treating or preventing breast cancer
TW201907946A (en) 2007-02-02 2019-03-01 美商艾瑟勒朗法瑪公司 ActRIIB variants derived from their use
TWI459963B (en) 2007-02-09 2014-11-11 Acceleron Pharma Inc Pharmaceutical composition comprising an actriia-fc fusion protein; use of an actriia-fc fusion protein for treatment or prevention of cancer-related bone loss;use of an actriia-fc fusion protein for the treatment or prevention of multiple myeloma
CN103877564A (en) 2007-09-18 2014-06-25 阿塞勒隆制药公司 Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
PL2340031T3 (en) 2008-08-14 2019-10-31 Acceleron Pharma Inc Gdf traps for use to treat anemia
CN104805105A (en) 2009-06-12 2015-07-29 阿塞勒隆制药公司 Truncated ACTRIIB-FC fusion proteins
AU2010322011B2 (en) 2009-11-17 2016-03-31 Acceleron Pharma Inc. ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
AU2011326586A1 (en) 2010-11-08 2013-05-30 Acceleron Pharma, Inc. ActRIIA binding agents and uses thereof
CN104936605A (en) 2012-11-02 2015-09-23 细胞基因公司 Activin-actrii antagonists and uses for treating bone and other disorders
JP2017523140A (en) 2014-06-13 2017-08-17 アクセルロン ファーマ, インコーポレイテッド Methods and compositions for treating ulcers

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE3374837D1 (en) 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
EP0143949B1 (en) 1983-11-01 1988-10-12 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Pharmaceutical composition containing urokinase
AU648505B2 (en) 1989-05-19 1994-04-28 Amgen, Inc. Metalloproteinase inhibitor
PT1129190E (en) 1998-11-13 2007-08-08 Immunex Corp Human tslp dna and polypeptides
JP4038118B2 (en) 2002-11-29 2008-01-23 株式会社コガネイ Fluid pressure cylinder
JO3324B1 (en) * 2006-04-21 2019-03-13 Amgen Inc Lyophilized Therapeutic Peptibody Formulations
US7947646B2 (en) * 2007-03-06 2011-05-24 Amgen Inc. Variant activin receptor polypeptides
KR101778134B1 (en) * 2008-11-26 2017-09-13 암젠 인크 Variants of activin iib receptor polypeptides and uses thereof
US9401875B2 (en) 2012-06-01 2016-07-26 Nippon Telegraph And Telephone Corporation Packet transfer processing method and packet transfer processing device
US9300829B2 (en) 2014-04-04 2016-03-29 Canon Kabushiki Kaisha Image reading apparatus and correction method thereof
WO2016205370A1 (en) * 2015-06-15 2016-12-22 Santa Maria Biotherapeutics, Inc. Methods of using activin receptor iib-based proteins

Also Published As

Publication number Publication date
PE20170471A1 (en) 2017-05-14
AU2015274293A1 (en) 2017-02-02
EP3155008A4 (en) 2018-05-16
CN107074931A (en) 2017-08-18
WO2015192127A3 (en) 2016-03-17
MX2016016281A (en) 2017-03-31
AP201609647A0 (en) 2016-12-31
CL2016003191A1 (en) 2017-11-10
EP3155008A2 (en) 2017-04-19
KR20170035891A (en) 2017-03-31
EA201692568A1 (en) 2017-05-31
TN2016000551A1 (en) 2018-04-04
CA2952231A1 (en) 2015-12-17
WO2015192127A2 (en) 2015-12-17
BR112016029211A2 (en) 2018-01-30
TW201625675A (en) 2016-07-16
PH12016502479A1 (en) 2017-04-10
JP2017519009A (en) 2017-07-13

Similar Documents

Publication Publication Date Title
GB2531928B (en) Image-stitching for dimensioning
HK1217861A1 (en) Wifi-coordinated laa-lte
GB201817189D0 (en) Image-stitching for dimensioning
IL250583D0 (en) Anti-tigit antibodies
GB2530832B (en) Deletion mutations
GB201602284D0 (en) Early entry
SG11201703403TA (en) Anti-tim-3 antibodies
EP3155008A4 (en) Formulated receptor polypeptides and related methods
HK1226082A1 (en) Mhc class i epitope delivering polypeptides
IL266570D0 (en) Syntac polypeptides and uses thereof
AU360060S (en) Lighter
IL252004D0 (en) Domain-exchanged antibody
SG11201703767XA (en) Anti-interleukin-33 antibodies and uses thereof
GB201419094D0 (en) Anti-TIM-3-antibodies
GB201404893D0 (en) Selfie - Stick
SI3126388T1 (en) Anti-egfrviii antibodies and uses thereof
AU361515S (en) Dishrack
SG11201606367YA (en) 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof
IL252216D0 (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
GB2528557B (en) Soundbar
TWM490648U (en) Keyboard device
GB201409525D0 (en) Morphable apparatus
GB2529896B (en) Multirotor
SI3097397T1 (en) Schienenmesssystem
GB201404470D0 (en) Therapeutic methods and materials